S. Schmitt

P06.07 IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL

M. Subklewe, S. Kobold, A. Gottschlich, 2021 .

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

B. Vick, I. Jeremias, A. Humpe, 2021, Journal of Hematology & Oncology.

Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells

H. Leonhardt, C. Josenhans, M. Griffioen, 2020, Frontiers in Immunology.

A modular and controllable T cell therapy platform for acute myeloid leukemia

C. Klein, S. Endres, M. Subklewe, 2021, Leukemia.